Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Refsum disease]

I Hochner1, J F Blickle, J M Brogard

  • 1Service de médecine interne, HUS, 1, place de l'Hôpital, Strasbourg, France.

La Revue De Medecine Interne
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Refsum's disease is a rare genetic disorder caused by phytanic acid buildup. Dietary changes and plasmapheresis can manage neuropathy symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Key priorities in managing glucose control in older people with diabetes.

The journal of nutrition, health & aging·2009
Same author

Diabetic nephropathy in the elderly.

Diabetes & metabolism·2007
Same author

Thiazolidinediones for the treatment of type 2 diabetes.

European journal of internal medicine·2007
Same author

Meglitinide analogues: a review of clinical data focused on recent trials.

Diabetes & metabolism·2006
Same author

Hematological response to short-term oral cyanocobalamin therapy for the treatment of cobalamin deficiencies in elderly patients.

The journal of nutrition, health & aging·2006
Same author

Management of hypertension in elderly diabetic patients.

Diabetes & metabolism·2006
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
Same journal

[Patient similarity: When the internist's reasoning meets artificial intelligence].

La Revue de medecine interne·2026
Same journal

[Satisfaction of healthcare professionals within a multidisciplinary day-hospitalization for patients with systemic autoimmune rare disease].

La Revue de medecine interne·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Context:

  • Refsum's disease is an autosomal recessive disorder.
  • It primarily affects individuals of Scandinavian and Northern European descent.
  • The condition stems from a deficiency in phytanic acid catabolism.

Purpose:

  • To describe the pathophysiology, clinical manifestations, diagnosis, and treatment of Refsum's disease.
  • To highlight the role of phytanic acid accumulation in disease progression.
  • To evaluate treatment efficacy.

Summary:

  • Refsum's disease results from impaired phytanic acid breakdown, leading to its accumulation in tissues.
  • Clinical features include retinitis pigmentosa, peripheral neuropathy, ataxia, and elevated cerebrospinal fluid protein.

Related Experiment Videos

  • Diagnosis is confirmed by measuring serum phytanic acid levels.
  • Impact:

    • Dietary modification and plasmapheresis are the primary treatments.
    • Treatment is effective for neuropathy but less so for visual and cranial nerve impairments.
    • Understanding the disease aids in managing patient care and potential therapeutic strategies.